Vitalis
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9171 Towne Centre Dr Ste 350, San Diego,...Phone Number
(540) 368-1690Website
www.vitalispharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vitalis
Vitalis Therapeutics is a pharmaceutical company focused on developing non-opioid pain management therapies specifically for patients undergoing Total Knee Arthroplasty (TKA). The company aims to address the significant pain concerns of TKA patients by providing safer alternatives to opioids. Their innovative approach includes exploring the use of oral ketamine as a potential breakthrough in pain relief. Vitalis Therapeutics is committed to improving patient outcomes and reducing reliance on opioids in pain management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vitalis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vitalis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vitalis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vitalis has new funding data
Check if Vitalis has recently received funding, and reach out quickly before it becomes old news!
Check out if Vitalis is spiking on competitors!
Product Launch: Get notified when Vitalis launches new products
Earning: See what the market has to say on Vitalis recently announced quarterly report
Vitalis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Vitalis
Find 3 more new buyers
Compare Similar Companies to Vitalis
Compare insights from companies similar to Vitalis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vitalis
<$5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Vitalis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vitalis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vitalis.
Vitalis Tech Stack
A closer look at the technologies used by Vitalis
Vitalis News & Media
Vitalis to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vitalis LLC, a specialty pharmaceutical company leveraging its proprietary VTS platform to overcome the limitations of existing drugs and enhance patient experience across a variety of therapeutic areas including multiple sclerosis and post-operative pain, today announced Joseph Habboushe, M.D., MBA., Chief Executive Officer and founder, will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020 at 5:Vitalis Receives Orphan Drug Designation for Diroximel Fumarate and Monomethyl Fumarate, in Combination with VTS-Aspirin, for Multiple Sclerosis Patients Who Experience Fumarate Flush
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Vitalis LLC, a specialty pharmaceutical company leveraging its proprietary VTS-Aspirin platform to overcome the limitations of existing drugs and enhance patient experience across a variety of therapeutic areas, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for diroximel fumarate (commercially available as Vumerity®) and monomethyl fumarate (FDA approved as Bafiertam™), both in combinatiVitalis Pharmaceuticals Announces Results of Type C Meeting with FDA for VTS-72
Phase 3 Study Expected to Initiate in 2020, with Potential for First New Drug Application in Acute Flush in Multiple Sclerosis (MS) Patients in First Half 2021
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vitalis
Sign Up For FreeTo access detailed company insights
Vitalis Therapeutics is a pharmaceutical company focused on developing non-opioid pain management therapies specifically for patients undergoing Total Knee Arthroplasty (TKA). The company aims to address the significant pain concerns of TKA patients by providing safer alternatives to opioids. Their innovative approach includes exploring the use of... Read More
